325 related articles for article (PubMed ID: 18333886)
1. Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection.
Nawabi P; Catron DM; Haldar K
Mol Microbiol; 2008 Apr; 68(1):173-85. PubMed ID: 18333886
[TBL] [Abstract][Full Text] [Related]
2. SsaM and SpiC interact and regulate secretion of Salmonella pathogenicity island 2 type III secretion system effectors and translocators.
Yu XJ; Liu M; Holden DW
Mol Microbiol; 2004 Nov; 54(3):604-19. PubMed ID: 15491354
[TBL] [Abstract][Full Text] [Related]
3. SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.
Coombes BK; Lowden MJ; Bishop JL; Wickham ME; Brown NF; Duong N; Osborne S; Gal-Mor O; Finlay BB
Infect Immun; 2007 Feb; 75(2):574-80. PubMed ID: 17158898
[TBL] [Abstract][Full Text] [Related]
4. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane.
Ruiz-Albert J; Yu XJ; Beuzón CR; Blakey AN; Galyov EE; Holden DW
Mol Microbiol; 2002 May; 44(3):645-61. PubMed ID: 11994148
[TBL] [Abstract][Full Text] [Related]
5. Intracellular Salmonella enterica redirect exocytic transport processes in a Salmonella pathogenicity island 2-dependent manner.
Kuhle V; Abrahams GL; Hensel M
Traffic; 2006 Jun; 7(6):716-30. PubMed ID: 16637890
[TBL] [Abstract][Full Text] [Related]
6. The Salmonella enterica serovar typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole.
Freeman JA; Ohl ME; Miller SI
Infect Immun; 2003 Jan; 71(1):418-27. PubMed ID: 12496192
[TBL] [Abstract][Full Text] [Related]
7. SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium.
Kujat Choy SL; Boyle EC; Gal-Mor O; Goode DL; Valdez Y; Vallance BA; Finlay BB
Infect Immun; 2004 Sep; 72(9):5115-25. PubMed ID: 15322005
[TBL] [Abstract][Full Text] [Related]
8. The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice.
Jiang X; Rossanese OW; Brown NF; Kujat-Choy S; Galán JE; Finlay BB; Brumell JH
Mol Microbiol; 2004 Dec; 54(5):1186-98. PubMed ID: 15554961
[TBL] [Abstract][Full Text] [Related]
9. Salmonella Pathogenicity Island 4 encodes a giant non-fimbrial adhesin and the cognate type 1 secretion system.
Gerlach RG; Jäckel D; Stecher B; Wagner C; Lupas A; Hardt WD; Hensel M
Cell Microbiol; 2007 Jul; 9(7):1834-50. PubMed ID: 17388786
[TBL] [Abstract][Full Text] [Related]
10. A limited role for SsrA/B in persistent Salmonella Typhimurium infections in pigs.
Boyen F; Pasmans F; Van Immerseel F; Morgan E; Botteldoorn N; Heyndrickx M; Volf J; Favoreel H; Hernalsteens JP; Ducatelle R; Haesebrouck F
Vet Microbiol; 2008 Apr; 128(3-4):364-73. PubMed ID: 18068913
[TBL] [Abstract][Full Text] [Related]
11. Multiple Salmonella-pathogenicity island 2 effectors are required to facilitate bacterial establishment of its intracellular niche and virulence.
Knuff-Janzen K; Tupin A; Yurist-Doutsch S; Rowland JL; Finlay BB
PLoS One; 2020; 15(6):e0235020. PubMed ID: 32584855
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis.
Coombes BK; Coburn BA; Potter AA; Gomis S; Mirakhur K; Li Y; Finlay BB
Infect Immun; 2005 Nov; 73(11):7161-9. PubMed ID: 16239510
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide identification of novel genomic islands that contribute to Salmonella virulence in mouse systemic infection.
Haneda T; Ishii Y; Danbara H; Okada N
FEMS Microbiol Lett; 2009 Aug; 297(2):241-9. PubMed ID: 19583791
[TBL] [Abstract][Full Text] [Related]
14. Functional dissection of SseF, a type III effector protein involved in positioning the salmonella-containing vacuole.
Abrahams GL; Müller P; Hensel M
Traffic; 2006 Aug; 7(8):950-65. PubMed ID: 16800847
[TBL] [Abstract][Full Text] [Related]
15. Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine.
Brown NF; Vallance BA; Coombes BK; Valdez Y; Coburn BA; Finlay BB
PLoS Pathog; 2005 Nov; 1(3):e32. PubMed ID: 16304611
[TBL] [Abstract][Full Text] [Related]
16. The chaperone binding domain of SopE inhibits transport via flagellar and SPI-1 TTSS in the absence of InvB.
Ehrbar K; Winnen B; Hardt WD
Mol Microbiol; 2006 Jan; 59(1):248-64. PubMed ID: 16359332
[TBL] [Abstract][Full Text] [Related]
17. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA.
Beuzón CR; Méresse S; Unsworth KE; Ruíz-Albert J; Garvis S; Waterman SR; Ryder TA; Boucrot E; Holden DW
EMBO J; 2000 Jul; 19(13):3235-49. PubMed ID: 10880437
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of proteins extracted from the surface of Salmonella Typhimurium grown under SPI-2-inducing conditions by LC-ESI/MS/MS sequencing.
Sherry AE; Inglis NF; Stevenson A; Fraser-Pitt D; Everest P; Smith DG; Roberts M
Proteomics; 2011 Feb; 11(3):361-70. PubMed ID: 21268266
[TBL] [Abstract][Full Text] [Related]
19. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2.
Kuhle V; Hensel M
Cell Mol Life Sci; 2004 Nov; 61(22):2812-26. PubMed ID: 15558211
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.
Hayward RD; Cain RJ; McGhie EJ; Phillips N; Garner MJ; Koronakis V
Mol Microbiol; 2005 May; 56(3):590-603. PubMed ID: 15819617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
